Cargando…

Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma

The devastating prognosis of hepatocellular carcinoma (HCC) is partially attributed to chemotherapy resistance. Accumulating evidence suggests that the epithelial-mesenchymal transition (EMT) is a key driving force of carcinoma metastasis and chemoresistance in solid tumors. Leucine-rich repeat-cont...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Zhili, Guo, Deliang, Wang, Quanxiong, Liu, Pengpeng, Xiao, Yushao, Wu, Ping, Wang, Yitao, Chen, Baiyang, Liu, Zhisu, Liu, Quanyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6568175/ https://www.ncbi.nlm.nih.gov/pubmed/31244936 http://dx.doi.org/10.7150/thno.30562

Ejemplares similares

Cancer cell membrane-camouflaged MOF nanoparticles for a potent dihydroartemisinin-based hepatocellular carcinoma therapy
por: Xiao, Yusha, et al.
Publicado: (2020)

Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1
por: Liu, Pengpeng, et al.
Publicado: (2022)

A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
por: Guo, Deliang, et al.
Publicado: (2021)

Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
por: Gu, Yang, et al.
Publicado: (2020)

DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress
por: Guo, Deliang, et al.
Publicado: (2021)

A Novel End-to-End Biliary-to-Biliary Anastomosis Technique for Iatrogenic Bile Duct Injury of Strasberg-Bismuth E1-4 Treatment: A Retrospective Study and in vivo Assessment
por: Ma, Dong, et al.
Publicado: (2021)

Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis
por: Xiao, Juan, et al.
Publicado: (2015)

Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review
por: Lan, Jianwei, et al.
Publicado: (2021)

LGR5 and LGR6 in stem cell biology and ovarian cancer
por: Schindler, Adam J., et al.
Publicado: (2017)

FCN3 inhibits the progression of hepatocellular carcinoma by suppressing SBDS-mediated blockade of the p53 pathway
por: Ma, Dong, et al.
Publicado: (2023)

OTU deubiquitinase 5 inhibits the progression of non‐small cell lung cancer via regulating p53 and PDCD5
por: Kang, Xiao‐yun, et al.
Publicado: (2020)

Characterization of the Transcriptomes of Lgr5+ Hair Cell Progenitors and Lgr5- Supporting Cells in the Mouse Cochlea
por: Cheng, Cheng, et al.
Publicado: (2017)

LGR4 and LGR5 Function Redundantly During Human Endoderm Differentiation
por: Tsai, Yu-Hwai, et al.
Publicado: (2016)

RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer
por: Xi, Hong-Qing, et al.
Publicado: (2017)

Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy
por: Xu, Liangliang, et al.
Publicado: (2019)

Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin
por: CHANG, LEI, et al.
Publicado: (2016)

Anatomically and Functionally Distinct Lung Mesenchymal Populations Marked by Lgr5 and Lgr6
por: Lee, Joo-Hyeon, et al.
Publicado: (2017)

LGR4 and LGR5 form distinct homodimers that only LGR4 complexes with RNF43/ZNRF3 to provide high affinity binding of R-spondin ligands
por: Toh, Yukimatsu, et al.
Publicado: (2023)

Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
por: Wang, Yitao, et al.
Publicado: (2017)

Retraction Note: Up-regulation of CDK16 by multiple mechanisms in hepatocellular carcinoma promotes tumor progression
por: Wang, Yitao, et al.
Publicado: (2019)

Lgr5(+) intestinal stem cell sorting and organoid culture
por: Liu, Ruixue, et al.
Publicado: (2019)

Evaluation of Targeted Agents for Advanced and Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis
por: Guo, Tao, et al.
Publicado: (2019)

Identifying the superior antibiotic prophylaxis strategy for breast surgery: A network meta-analysis
por: Guo, Tao, et al.
Publicado: (2019)

Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo
por: WANG, DONGLIANG, et al.
Publicado: (2014)

Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma
por: Mizuno, Nobumasa, et al.
Publicado: (2013)

Anti-Inflammatory Effects of Recombinant Human PDCD5 (rhPDCD5) in a Rat Collagen-Induced Model of Arthritis
por: Xiao, Juan, et al.
Publicado: (2014)

Lgr5(+) cells are required and dynamically participate in olfactory epithelium regeneration: a revisiting shows Lgr5 expression in multiple cell lineages
por: Ren, Wenwen, et al.
Publicado: (2022)

The p53 binding protein PDCD5 is not rate-limiting in DNA damage induced cell death
por: Bock, Florian J., et al.
Publicado: (2015)

R-Spondin Potentiates Wnt/β-Catenin Signaling through Orphan Receptors LGR4 and LGR5
por: Ruffner, Heinz, et al.
Publicado: (2012)

LGR4 and LGR5 Regulate Hair Cell Differentiation in the Sensory Epithelium of the Developing Mouse Cochlea
por: Żak, Magdalena, et al.
Publicado: (2016)

Identifying the Best Anticancer Agent Combination in TACE for HCC Patients: A Network Meta-analysis
por: Guo, Tao, et al.
Publicado: (2018)

Lgr5-positive cells in the lung and their clinical significance in patients with lung adenocarcinoma
por: Zhang, Xiaohan, et al.
Publicado: (2016)

Feasibility and Efficacy of S-Adenosyl-L-methionine in Patients with HBV-Related HCC with Different BCLC Stages
por: Guo, Tao, et al.
Publicado: (2016)

Expression and Prognostic Value of Lgr5 in Patients with Recurrent Nasopharyngeal Carcinoma
por: Xu, Haoyuan, et al.
Publicado: (2023)

The reduced PDCD5 protein is correlated with the degree of tumor differentiation in endometrioid endometrial carcinoma
por: Gao, Meng, et al.
Publicado: (2016)

Monolayer culture of intestinal epithelium sustains Lgr5(+) intestinal stem cells
por: Liu, Yuan, et al.
Publicado: (2018)

YY1-Targeted RBM15B Promotes Hepatocellular Carcinoma Cell Proliferation and Sorafenib Resistance by Promoting TRAM2 Expression in an m6A-Dependent Manner
por: Tan, Chunzhong, et al.
Publicado: (2022)

LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer
por: Cao, Hao-Zhe, et al.
Publicado: (2017)

LGR5 marks targetable tumor-initiating cells in mouse liver cancer
por: Cao, Wanlu, et al.
Publicado: (2020)

LGR5 is required for the maintenance of spheroid-derived colon cancer stem cells
por: CHEN, XIANG, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_f1a3mrs568o7mo374j7n82nn57